- About Us
- What We Do
- How We Heal
- Products
- Cartilage Repair Device
- Medeor™ Matrix for Soft Tissue Repair
- Meso BioMatrix™ Scaffold for Soft Tissue Repair
- Epi-Guide® Bioresorbable Barrier Matrix
- OsseoFit™ Porous Tissue Matrix™
- Vitoss® Scaffold Foam™ Products
- Angio-Seal™ Vascular Closure Device
- QuickCat™ Extraction Catheter
- ThromCat® Thrombectomy System
- Technology Platforms
- How We Partner
- Investor Relations
In 1984, innovators John Nash and Kenneth Kensey, M.D. co-founded the Kensey Nash Corporation with only two employees—themselves. Since then, Kensey Nash has expanded to more than 275 employees with a management team that represents some of the most experienced professionals in the industry.
Executive Officers
Joseph W. Kaufmann
President and CEO
With KNC since 1989
Douglas G. Evans, P.E.
Chief Operating Officer
With KNC since 1989
Michael Celano
Chief Financial Officer
With KNC since 2009
John E. Nash, P.E.
Vice President of New Technology and Co-Founder
With KNC since 1984
James (Ted) Rauth, P.E.
Vice President of Operations
With KNC since 1999
Todd M. DeWitt
Vice President of Biomaterials
With KNC since 1988
Senior Management
Donald L. Daveler
Vice President of Quality Assurance/ Quality Control
With KNC since 1990
Thomas M. Maguire
Vice President of Clinical and Regulatory
With KNC since 2008
Jeffrey C. Kelly, Esq.
Vice President of Legal Affairs
With KNC since 2000
William Fiehler
Vice President of Product Development
With KNC since 2007
- About Us
- What We Do
- How We Heal
- Products
- Cartilage Repair Device
- Medeor™ Matrix for Soft Tissue Repair
- Meso BioMatrix™ Scaffold for Soft Tissue Repair
- Epi-Guide® Bioresorbable Barrier Matrix
- OsseoFit™ Porous Tissue Matrix™
- Vitoss® Scaffold Foam™ Products
- Angio-Seal™ Vascular Closure Device
- QuickCat™ Extraction Catheter
- ThromCat® Thrombectomy System
- Technology Platforms
- How We Partner
- Investor Relations

